Lai Wang Sells 5,000 Shares of Beigene, Ltd. (NASDAQ:ONC) Stock

Beigene, Ltd. (NASDAQ:ONC) insider Lai Wang sold 5,000 shares of the firm’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $257.23, for a total value of $1,286,150.00. Following the sale, the insider now directly owns 920,920 shares in the company, valued at $236,888,251.60. This trade represents a 0.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Beigene Stock Performance

Beigene stock traded up $1.21 during mid-day trading on Tuesday, hitting $259.70. The company had a trading volume of 619,630 shares, compared to its average volume of 378,820. The company has a quick ratio of 1.72, a current ratio of 1.93 and a debt-to-equity ratio of 0.05. Beigene, Ltd. has a 1 year low of $126.97 and a 1 year high of $265.89. The firm has a market capitalization of $25.41 billion, a P/E ratio of -31.52, a P/E/G ratio of 7.73 and a beta of 0.63.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.